DEADLINE: TTRA Drugs and Devices Funding EOI

TTRA Drugs and Devices can provide up to $1.5 million to help eligible Australian start-ups, spin-outs and SMEs develop innovative preventative, diagnostic, therapeutic and/or disease management drugs and devices for cardiovascular disease and the complications of diabetes (type 1 and type 2).